ODR · Daily industry brief

The regulatory read for hormone and peptide clinics, every morning.

FDA, DEA, and Federal Register movement translated into what your clinic changes Monday. Primary sources with dates. Confirmed and rumored kept apart. No hype, no product promotion, no medical advice.

Free. Written for prescribers, clinic operators, and the people who market for them. Unsubscribe any time.

What we cover

• Compounding and the bulks lists. 503A, 503B, PCAC, and Category 1/2 movement, without the conflations.
• Telehealth and the DEA clock. The flexibilities run through December 31, 2026. We track what replaces them.
• GLP-1 enforcement. Warning letters, the 503B exclusion rulemaking, and what it means for supply.
• Operator and supplier intel. Who is moving, which facilities drew a 483, what it means for your sourcing.
• Marketing compliance. What is no longer sayable in ads, before the FTC tells you personally.